G-CON Manufacturing to supply PODs for GenCure BioManufacturing Center

March 29, 2019

GenCure has selected G-CON Manufacturing, a major producer of prefabricated, flexible cleanroom solutions, for its new multi-product cellular therapy facility.

The new facility, which will anchor the VelocityTX innovation center in San Antonio, will expand capabilities of the GenCure BioManufacturing Center, providing new state-of-the-art manufacturing capabilities to support clinical cell therapy trials.

The PODs will provide approximately 6,700 square feet of cleanroom space to facilitate production of the large numbers of consistent, high-quality, clinical-grade adult stem cells needed to help bring potential new therapies into human clinical trials.

The site is designed to facilitate future expansion up to 14,000 square feet of cleanroom capacity. Being prefabricated and largely autonomous, PODs are ideal for the planned expansion phases while avoiding impact to ongoing manufacturing.

“We are very excited and grateful for the opportunity to design and build PODs for this important project at GenCure,” said Peter Makowenskyj, Director of Sales Engineering at G-CON Manufacturing.

“Cell therapies can successfully treat previously unmet medical needs and for that reason are one of the fastest growing segments in our industry. Based on our experience in this space, G-CON is well prepared to support GenCure’s needs by providing the fastest and most flexible technology available in the cleanroom market.

Becky Cap, Senior Vice President of BioBridge Global and Chief Operating Officer for GenCure, said “there is a pent-up demand for stem cells needed to bring potential new cellular therapies into clinical trials, and the major bottleneck in the system is a lack of biomanufacturing capacity.”

“An important benefit of G-CON’s prefabricated modular cleanroom system is that it will speed up the design, build and validation process for our production facilities, supporting our goal of bringing the first phase of this new biomanufacturing space online by the end of the year,” she said.

The PODs will be built and factory-acceptance tested at G-CON’s facility in College Station, Texas, then shipped San Antonio and site-acceptance tested to assure full functionality.

G-CON Manufacturing designs, produces and installs prefabricated cleanroom PODs. G-CON’s cleanroom POD portfolio encompasses a variety of different dimensions and purposes, from laboratory environments to personalized medicine and production process platforms. The POD cleanroom units are unique from traditional cleanroom structures due to the ease of scalability, mobility and the ability to repurpose the PODs once the production process reaches the end of its lifecycle.

About GenCure: GenCure, a subsidiary of San Antonio-based nonprofit BioBridge Global, is focused on enabling the development of cell-based therapies by providing access to source materials, cGMP biomanufacturing experience and clinical research support. GenCure focuses on regenerative medicine through the Texas Cord Blood Bank, biomanufacturing facility, apheresis center and a deceased donor tissue bank. Learn more at GenCure.org